Health Press Releases & Articles 501 - 505 of 771
Study Shows Otamixaban Substantially Reduced Complications Of Invasive Managemen
31st August 2009 -
Views: 861
The results of the SEPIA-ACS1/ TIMI-42 were presented today at the plenary session of the Annual European Society of Cardiology congress in Barcelona and simultaneously published online in The Lancet.
Father Of The Year Li Cunxin A Stellar Aussie Dad, Says Cochlear
28th August 2009 -
Views: 1197
Dr Chris Roberts, CEO of Cochlear Limited the global leader in cochlear and bone conduction implant technology and a proud sponsor of the Shepherd Centre Father of the Year Awards has congratulated Li Cunxin, 2009 Father of the Year, calling him "a stellar Australian father."
Data From Largest Gold Stage Ii Patient Population Treated With Tiotropium Highlight The Benefits Of
28th August 2009 -
Views: 817
A new analysis of the landmark UPLIFT(R) trial, published today in the Lancet, shows that tiotropium (SPIRIVA(R) Handihaler(R) 18 micro g) administered to Chronic Obstructive Pulmonary Disease (COPD) patients with moderate disease severity (GOLD - Global Initiative for Chronic Obstructive Lung Disease - Stage II) produced significant and sustained improvements in lung function for up to 4 years.[1]
Magid Abou-gharbia, Ph.d., Frsc Joins Laxai As Scientific Advisor
28th August 2009 -
Views: 858
LAXAI, a Leading Contract Research Organization based in the U.S. and India providing integrated services
across the drug discovery and development spectrum, today announced that Magid Abou-Gharbia, Ph.D., FRSC
has joined the company as its Scientific Advisor.
Spinal Implant Developed By Sanford Clinic Neurosurgeon Receives Fda 510(k) Market Clearance As A Lu
28th August 2009 -
Views: 875
Sanford Health ( www.sanfordhealth.org ), a comprehensive health care provider in the Upper Midwest, announced today a spinal implant developed by Sanford Clinic Neurosurgeon, Wilson Asfora, MD, Sanford Clinic Neurosurgery & Spine, has received United States Food and Drug Administration (FDA) 510(k) market clearance as a lumbar intervertebral body fusion device.
NEWS 
